Holen Sie sich die Stockscreener-App
86.67
0.85%
-0.74
Handel nachbörslich:
86.78
0.11
+0.13%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Abbott Laboratories Aktie (ABT) Neueste Nachrichten
Abbott Laboratories stock (US0028241000): investors weigh diagnostics strength and medical-device he - AD HOC NEWS
Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026 - PR Newswire
Abbott Laboratories (ABT) Slid on Headwinds in Nutrition Business - Yahoo Finance
Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Today's Market - The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Abbott Laboratories (ABT) Stock Analysis: Tapping Into A 35.73% Potential Upside - DirectorsTalk Interviews
Reassessing Abbott Laboratories (ABT) After A 32% One Year Share Price Decline - Yahoo Finance
Abbott Deepens Digital Health Push With New Cardiovascular Diagnostics And Wearables - simplywall.st
Abbott Laboratories stock is getting decimated, but the smart money senses opportunity - MSN
Abbott Laboratories Stock Is Getting Decimated, But the Smart Money Senses Opportunity - Barchart.com
Has the Abbott Laboratories Sell-Off Finally Created an Entry Point? - AOL.com
Abbott Laboratories (ABT) Slid Due To Its Nutrition Segment’s Sensitivity to Consumer Spending Momentum - Insider Monkey
Waiting on Integration Result, Market Stays Moderated on Abbott Laboratories (ABT) - Insider Monkey
Three Recession-Resistant Stocks Worth Investors’ Attention - NAI500
Abbott’s Lingo Wearable And Cardio R&D Reframe Long Term Growth Story - Yahoo Finance
Abbott Laboratories, Coca-Cola, and Walmart: Top Recession-Proof Stocks for 2026News and Statistics - IndexBox
ABT Stock Chart | ABBOTT LABORATORIES (NYSE:ABT) - ChartMill
Abbott Laboratories cuts outlook, says mild flu season hurt sales - MSN
Has the Abbott Laboratories sell-off finally created an entry point? - MSN
Long term debt to total equity ratio of Abbott Laboratories – BVL:ABTUS - TradingView
Abbott Laboratories Balance Sheet – BVL:ABTUS - TradingView
NEC Baby Formula Lawsuit & Settlement | May 2026 Update - Lawsuit Information Center
Buying pulsed field ablation systems: What hospitals should know - Modern Healthcare
3 Stocks to Buy if You Think the Economy Is Heading for a Recession - The Motley Fool
Abbott Laboratories stock (US0028241000): diabetes business and latest earnings in focus - AD HOC NEWS
Abbott Laboratories stock (US0028241000): investors eye upcoming Q4 2025 earnings call and biosimila - AD HOC NEWS
Better medical device stock right now: Abbott Laboratories vs. Dexcom - MSN
Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum - Yahoo Finance
Abbott Laboratories stock (US0028241000): steady medical devices player after latest quarterly updat - AD HOC NEWS
Worker says Abbott fired him over a chat his coworker started - hcamag.com
ECMC debuts new high-tech blood & urine lab to cut down on processing times by 20 percent - WKBW
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott Spinal Cord Stimulator Problems Resulted in Severe Paralysis: Lawsuit - AboutLawsuits.com
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $109 - 富途牛牛
Abbott Laboratories Insiders Added US$4.23m Of Stock To Their Holdings - Yahoo Finance
Abbott Laboratories stock (US0028241000): steady momentum after latest earnings and diabetes tech pu - AD HOC NEWS
Has The Recent Slide In Abbott Laboratories (ABT) Opened Up A Valuation Opportunity? - simplywall.st
Build-A-Bear Workshop and Abbott Laboratories o... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
A Look at Abbott Laboratories (ABT) After 4.1% Gain -- GF Value $127.69 vs Price $87.91 - GuruFocus
Abbott Laboratories Stock (ABT) Moved Up by 3.04% on May 18: What Investors Need To Know - TradingKey
Boston Scientific Bets on Growth Through Strategic M&A Deals - TradingView
Raised full-year 2026 outlook lifts Abbott stock 3.18% - Traders Union
Abbott Laboratories (ABT) is attracting investor attention: Here is what you should know - MSN
Trump’s stock trading spree included North Chicago’s Abbott Labs - Crain's Chicago Business
Abbott stock posts modest gain amid fragile momentum below MA-20 resistance: weekly review - Traders Union
Abbott Laboratories slammed on its post-Exact Sciences guidance - MSN
ABT Stock Price and Chart — NYSE:ABT - TradingView
ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now? - TradingView
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Thrivent Financial for Lutherans Acquires 48,286 Shares of Abbott Laboratories $ABT - MarketBeat
North Dakota State Investment Board Purchases New Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories (ABT) Stock Analysis: Unlocking a 40% Potential Upside for Savvy Investors - DirectorsTalk Interviews
Abbott Laboratories $ABT Shares Purchased by Cambridge Investment Research Advisors Inc. - MarketBeat
Abbott Laboratories stock (US0028241000): Q1 2026 growth, guidance raise and diabetes momentum - AD HOC NEWS
Abbott Laboratories stock (US0028241000): diabetes growth and fresh guidance keep investors focused - AD HOC NEWS
Abbott Laboratories Stock (ABT) Opinions on Recent Price Declines - Quiver Quantitative
Abbott Laboratories stock (US0028241000): diabetes segment drives attention after latest quarterly u - AD HOC NEWS
Abbott Laboratories $ABT Stock Holdings Lowered by iA Global Asset Management Inc. - MarketBeat
AlphaCore Capital LLC Increases Stock Position in Abbott Laboratories $ABT - MarketBeat
Abacus Wealth Partners LLC Buys 12,260 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories Trade Ideas — LSX:850103 - TradingView
Assessing Abbott Laboratories (ABT) Valuation After Nutrition Setbacks Legal Uncertainty And Softer Analyst Sentiment - simplywall.st
Commerzbank Aktiengesellschaft FI Sells 131,572 Shares of Abbott Laboratories $ABT - MarketBeat
1.10%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):